Open AccessA Randomized Double-Blind Placebo-Control Feasibility Trial of Immunoglobulin Treatment for Prevention of Recurrent Acute Exacerbations of COPD
Author(s) -
Juthaporn Cowan,
Sunita Mulpuru,
Sara J. Abdallah,
Anchal Chopra,
Andrew Purssell,
Michaeline McGuinty,
Gonzalo G. Alvarez,
Antonio Giulivi,
Vicente F. Corrales–Medina,
Derek R. MacFadden,
Loree Boyle,
Delvina Hasimja,
Kednapa Thavorn,
Ranjeeta Mallick,
Shawn D. Aaron,
Donald W. Cameron
Publication year - 2021
Publication title -
international journal of chronic obstructive pulmonary disease/international journal of copd
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.394
H-Index - 67
eISSN - 1178-2005
pISSN - 1176-9106
DOI - 10.2147/copd.s338849
Subject(s) - medicine , randomized controlled trial , copd , adverse effect , quality of life (healthcare) , observational study , ambulatory , placebo , physical therapy , alternative medicine , nursing , pathology
Observational studies suggest that immunoglobulin treatment may reduce the frequency of acute exacerbations of COPD (AECOPD).